Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
Protocol STRI12 - Study to Reinforce Immunity (STRI) - A Phase 2 Double-Blind, Randomized,
Placebo-Controlled Study to Investigate the Safety and Efficacy of STRI Formula in
Non-Hospitalized Participants with COVID-19 (the Study)